Suppr超能文献

相似文献

1
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.
Oncoimmunology. 2017 Jul 13;6(10):e1347742. doi: 10.1080/2162402X.2017.1347742. eCollection 2017.
3
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
J Exp Med. 1996 Apr 1;183(4):1681-96. doi: 10.1084/jem.183.4.1681.
5
Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
World J Gastroenterol. 2016 Apr 7;22(13):3573-80. doi: 10.3748/wjg.v22.i13.3573.
8
Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage.
Cancer Immunol Res. 2017 May;5(5):397-407. doi: 10.1158/2326-6066.CIR-16-0348. Epub 2017 Mar 28.

引用本文的文献

1
Harnessing the immunotherapeutic potentials of gamma delta T cells against hematological malignancies.
Hemasphere. 2025 Aug 7;9(8):e70182. doi: 10.1002/hem3.70182. eCollection 2025 Aug.
2
Characteristics and significance of γδ T cells in colorectal cancer.
Oncoimmunology. 2025 Dec;14(1):2532231. doi: 10.1080/2162402X.2025.2532231. Epub 2025 Jul 28.
3
Mechanisms and Functions of γδ T Cells in Tumor Cell Recognition.
Curr Oncol. 2025 Jun 3;32(6):329. doi: 10.3390/curroncol32060329.
5
DOT cells for colorectal cancer immunotherapy.
Nat Cancer. 2025 May 1. doi: 10.1038/s43018-025-00965-8.
7
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.
Oncoimmunology. 2025 Dec;14(1):2485535. doi: 10.1080/2162402X.2025.2485535. Epub 2025 Apr 7.
9
Gamma delta T cells and their immunotherapeutic potential in cancer.
Biomark Res. 2025 Mar 28;13(1):51. doi: 10.1186/s40364-025-00762-6.

本文引用的文献

1
Assessment of tumor-infiltrating TCRV9V2 lymphocyte abundance by deconvolution of human cancers microarrays.
Oncoimmunology. 2017 Feb 6;6(3):e1284723. doi: 10.1080/2162402X.2017.1284723. eCollection 2017.
2
Ionic immune suppression within the tumour microenvironment limits T cell effector function.
Nature. 2016 Sep 22;537(7621):539-543. doi: 10.1038/nature19364. Epub 2016 Sep 14.
3
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.
Oncoimmunology. 2016 May 19;5(7):e1188246. doi: 10.1080/2162402X.2016.1188246. eCollection 2016 Jul.
4
The CXCL8-CXCR1/2 pathways in cancer.
Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25.
5
IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses.
Cancer Immunol Res. 2016 May;4(5):400-11. doi: 10.1158/2326-6066.CIR-15-0146. Epub 2016 Feb 29.
6
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.
Clin Cancer Res. 2015 Dec 15;21(24):5427-33. doi: 10.1158/1078-0432.CCR-15-0420. Epub 2015 Oct 30.
7
γδ T cells in cancer.
Nat Rev Immunol. 2015 Nov;15(11):683-91. doi: 10.1038/nri3904. Epub 2015 Oct 9.
8
The prognostic landscape of genes and infiltrating immune cells across human cancers.
Nat Med. 2015 Aug;21(8):938-945. doi: 10.1038/nm.3909. Epub 2015 Jul 20.
9
Robust enumeration of cell subsets from tissue expression profiles.
Nat Methods. 2015 May;12(5):453-7. doi: 10.1038/nmeth.3337. Epub 2015 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验